Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics, Molecular Diagnostics (PCR)), Animal (Companion, Food-producing animals), End User (Reference Labs, Hospital, Clinics, Universities)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global veterinary infectious disease diagnostics market size was exhibited at USD 3.16 billion in 2022 and is projected to hit around USD 7.56 billion by 2032, growing at a CAGR of 9.1% during the forecast period 2023 to 2032.

Growth can largely be attributed to the growth in the companion animal population, increasing incidence of transboundary and zoonotic diseases, rising demand for animal-derived food products, rising demand for pet insurance, growing animal health expenditure, and growth in the number of veterinary practitioners and income levels in developed economies. On the other hand, rising petcare costs is expected to restrain the overall market growth. Currently, the lack of skilled veterinarians and diagnostic infrastructure, especially in developing countries, is one of the major factors limiting the uptake of advanced diagnostic solutions among veterinarians. The high cost of advanced diagnostic tests is another major barrier to its widespread adoption.

 Veterinary Infectious Disease Diagnostics Market Report Scope

Veterinary Infectious Disease Diagnostics Market Dynamics

Drivers: Growth in the companion animal population

A surge in the overall companion animal population and adoption rate has been witnessed on a global scale. According to several studies, having a companion animal is associated with positive health benefits, such as reduced cardiac arrhythmias, normalization of blood pressure, decreased anxiety, greater psychological stability, and improved well-being. The increasing pet population is expected to drive the demand for pet care products and services, which, in turn, will support the growth of dependent industries such as veterinary infectious disease diagnostics.

North America:

• According to a National Pet Owners Survey (2019–2022) conducted by the American Pet Products Association (APPA), an estimated 70% of US households, or about 90.19 million families, owned a pet.
• Around 65.4 million households owned dogs, 49.7 million owned cats, and 2.6 million owned horses in the US in 2018.

Restraints: Rising pet care costs

The pet insurance market is expanding, the number of animals covered for treatments is still very low. As a result, animal owners generally bear the majority of the cost of treatments. In addition, according to the Society for Practicing Veterinary Surgeons, along with the increasing pet insurance, the cost of veterinary treatment is rising at a significant growth rate.

The number of consultations with veterinary specialists for pet care is another factor responsible for the increasing pet healthcare costs. Furthermore, the lower income in this profession compared to other advanced-degree professions such as dentistry and law puts pressure on veterinary professionals to increase their fees. High pet care costs directly impact the number of visits by pet owners to veterinary facilities, thereby restraining the growth of this market.

Opportunities: Increased use of PCR testing panels to rule out COVID-19 virus in animals

With regard to the current COVID-19 pandemic, animal health authorities have been carrying out tests to understand how the virus is affecting animals. So far, research studies and testing show that felines are more susceptible than other animals. Testing also shows that the virus spreads less from animal to animal as opposed to human-human or human-animal. It is expected that pet owners will increasingly start testing their pets for the absence of these diseases, thus increasing the demand for PCR panels for virus testing. This will create opportunities for new molecular diagnostics panels in the industry.

Challenges:  Shortage of veterinary practitioners in developing markets

The global animal healthcare industry is marked by a shortage of skilled veterinarians and pathologists. This is particularly evident in the emerging markets across countries like Brazil, China, and Southeast Asian countries, which show a huge gap in the demand and supply of veterinary professionals. Shortages are observed in developing countries such as. The majority of veterinarians across the globe work in private practices dedicated to companion animals, which leads to a shortage of resources for farm animals or food-producing animals.

Currently, the lack of skilled veterinarians and diagnostic infrastructure, especially in developing countries, is one of the major factors limiting the uptake of advanced diagnostic solutions among veterinarians. The high cost of advanced diagnostic tests is another major barrier to its widespread adoption.

North America is expected to account for the largest share of the veterinary infectious disease  diagnostics market in 2022

In 2022, North America accounted for the largest share of the global veterinary infectious disease diagnostics market. The growth in the veterinary diagnostics market of North America is characterized by the increasing population of companion and food-producing animals, rising meat and dairy product consumption, the availability of technologically advanced veterinary reference laboratories, rising veterinary healthcare expenditure, and growth in pet insurance coverage.

Recent Developments

• In April 2021, INDICAL BIOSCIENCE GmbH (Germany) acquired Boehringer Ingelheim’s  Svanova product portfolio which helped INDICAL widen its portfolio by adding 25 assays for livestock.
• In April 2021, BioChek (Netherlands) opened a new office in Johannesburg, South Africa.
• In January 2021, Heska Corporation (US) acquired Lacuna Diagnostics (US), this acquisition strengthened the company’s portfolio of point-of-care digital cytology technology and telemedicine services.
• In December 2020, NEOGEN Corporation (US) launched a preventative care DNA screening tool for detecting genetic diseases in dogs.
• In November 2020, NEOGEN Corporation (US) collaborated with Transnetyx Inc. (US), this partnership helped NEOGEN to increase its presence in the animal genomics and diagnostics market.

Some of the prominent players in the Veterinary Infectious Disease Diagnostics Market include:

• IDEXX Laboratories, Inc. (US),
• Zoetis, Inc. (US), 
• Thermo Fisher Scientific, Inc. (US), 
• Virbac (France),
• bioMérieux SA (France),
• Heska Corporation (US),
• IDvet (France),
• NEOGEN Corporation (US),
• QIAGEN N.V. (a part of INDICAL Bioscience) (Europe),
• Randox Laboratories Ltd. (UK),
• Agrolabo S.p.A. (Italy),
• Bio-Rad Laboratories (US), 
• Bionote, Inc. (South Korea),
• Biogal Galed Labs (Israel),
• BioChek (Netherlands),
• Biopanda Reagents (UK),
• URIT Medical Electronic Co. Ltd. (China),
• MEGACOR Diagnostik GmbH (Austria),
• LIVET (UK),
• INDICAL BIOSCIENCE GmbH (Germany),
• Fassisi GmbH (Germany),
• Alvedia (France),
• SKYER, Inc. (South Korea),
• Shenzhen Bioeasy Biotechnology Co., Ltd. (China),
• Precision Biosensor (US).

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Veterinary Infectious Disease Diagnostics market.

Veterinary  Infectious Disease Diagnostics Market, by Technology

• Immunodiagnostics
  • Lateral Flow Assays
  • ELISA Test
  • Other Immunodiagnostics Products
• Molecular Diagnostic
  • Polymerase Chain Reaction (PCR) Tests
  • Microarrays
  • Other Molecular Diagnostic Products
• Other Technologies

 Veterinary Infectious Disease Diagnostics Market, by Animal Type

• Companion Animals
  • Cats
  • Dogs
  • Horses
  • Other Companion Animals
• Companion Animals, By Infection Type
  • Viral Infections
  • Bacterial Infections
  • Parasitic Infections
  • Other Infections
• Food-producing Animals
  • Cattle
  • Pigs
  • Poultry
  • Other Food-producing animals
• Food-producing Animals, By Infection Type
  • Viral Infections
  • Bacterial Infections
  • Parasitic Infections
  • Other Infections

Veterinary Infectious Disease Diagnostics Market, by End User

• Reference Laboratories
• Veterinary Hospitals and Clinics
• Point-of-care/ In-house testing
• Research Institutes and Universities

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)